BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $158B
1-Year Est. Return 28.56%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+28.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$158B
AUM Growth
+$29.8B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
5,168
New
Increased
Reduced
Closed

Top Buys

1 +$2.84B
2 +$1.98B
3 +$1.94B
4
AMZN icon
Amazon
AMZN
+$1.5B
5
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$1.22B

Sector Composition

1 Technology 28.74%
2 Consumer Discretionary 11.24%
3 Financials 10.44%
4 Healthcare 9.19%
5 Communication Services 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPID icon
3901
Rapid Micro Biosystems
RPID
$183M
$32.2K ﹤0.01%
11,100
+7,474
WEST icon
3902
Westrock Coffee
WEST
$378M
$32.2K ﹤0.01%
7,908
+126
ATAI icon
3903
AtaiBeckley Inc
ATAI
$1.23B
$32K ﹤0.01%
7,832
+255
AVXL icon
3904
Anavex Life Sciences
AVXL
$431M
$31.9K ﹤0.01%
8,957
-24,822
BKKT icon
3905
Bakkt Inc
BKKT
$239M
$31.7K ﹤0.01%
3,161
+1,003
ACTG icon
3906
Acacia Research
ACTG
$394M
$31.7K ﹤0.01%
8,464
+1,135
MRSN
3907
DELISTED
Mersana Therapeutics
MRSN
$31.5K ﹤0.01%
1,090
+559
ACR
3908
ACRES Commercial Realty
ACR
$139M
$31.5K ﹤0.01%
1,476
+122
PGACR
3909
Pantages Capital Acquisition Corp Right
PGACR
$31.5K ﹤0.01%
+157,393
TUSK icon
3910
Mammoth Energy Services
TUSK
$102M
$31.5K ﹤0.01%
17,014
+1,544
VBNK
3911
VersaBank
VBNK
$459M
$31.5K ﹤0.01%
2,100
-100
SGU icon
3912
Star Group
SGU
$428M
$31.3K ﹤0.01%
+2,647
AAM.WS
3913
DELISTED
AA Mission Acquisition Corp Warrants
AAM.WS
$31.1K ﹤0.01%
183,119
MED icon
3914
Medifast
MED
$118M
$30.9K ﹤0.01%
2,897
+559
NODK icon
3915
NI Holdings
NODK
$270M
$30.9K ﹤0.01%
2,321
+199
ESCA icon
3916
Escalade
ESCA
$205M
$30.7K ﹤0.01%
2,274
+340
SES icon
3917
SES AI
SES
$413M
$30.7K ﹤0.01%
17,037
+15,695
MDV
3918
Modiv Industrial
MDV
$153M
$30.7K ﹤0.01%
2,131
-54
PLX icon
3919
Protalix BioTherapeutics
PLX
$211M
$30.6K ﹤0.01%
17,021
+1,806
PONY
3920
Pony AI Inc
PONY
$5.41B
$30.4K ﹤0.01%
+2,100
CMDB
3921
Costamare Bulkers Holdings
CMDB
$444M
$30.3K ﹤0.01%
1,968
+224
NTHI
3922
NeOnc Technologies
NTHI
$215M
$30.3K ﹤0.01%
+3,661
ELVR
3923
Elevra Lithium Ltd
ELVR
$888M
$30.2K ﹤0.01%
575
-691
NNNN
3924
Anbio Biotechnology
NNNN
$1B
$30.1K ﹤0.01%
1,000
-1,419
ACNT icon
3925
Ascent Industries
ACNT
$124M
$30K ﹤0.01%
1,853
-84